Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
50,895,662
-
Share change
-
+1,044,790
-
Total reported value
-
$6,123,921,590
-
Put/Call ratio
-
199%
-
Price per share
-
$120.34
-
Number of holders
-
252
-
Value change
-
+$154,989,187
-
Number of buys
-
118
-
Number of sells
-
145
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2019
As of 30 Jun 2019,
HAEMONETICS CORP - Common Stock (HAE) was held by
252 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,895,662 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital Research Global Investors, RENAISSANCE TECHNOLOGIES LLC, Neuberger Berman Group LLC, Jackson Square Partners, LLC, STATE STREET CORP, WELLS FARGO & COMPANY/MN, and FRANKLIN RESOURCES INC.
This page lists
252
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.